152
Views
0
CrossRef citations to date
0
Altmetric
Review

The safety of phthalate-containing medications used during pregnancy

, ORCID Icon &
Pages 293-302 | Received 13 Dec 2022, Accepted 18 Apr 2023, Published online: 05 May 2023

References

  • Benjamin S, Masai E, Kamimura N, et al. Phthalates impact human health: epidemiological evidences and plausible mechanism of action. J Hazard Mater. 2017;340:360–383.
  • Anderson WA, Castle L, Scotter MJ, et al. A biomarker approach to measuring human dietary exposure to certain phthalate diesters. Food Addit Contam. 2001;18(12):1068–1074.
  • Guo Y, Kannan K. Comparative assessment of human exposure to phthalate esters from house dust in China and the United States. Environ Sci Technol. 2011;45(8):3788–3794.
  • Mahto JK, Sharma M, Neetu N, et al. Conformational flexibility enables catalysis of phthalate cis-4,5-dihydrodiol dehydrogenase. Arch Biochem Biophys. 2022;727:109314.
  • Heudorf U, Mersch-Sundermann V, Angerer J. Phthalates: toxicology and exposure. Int J Hyg Environ Health. 2007;210(5):623–634.
  • Wang Y, Zhu H, Kannan K. A Review of Biomonitoring of Phthalate Exposures. Toxics. 2019;7(2). DOI:10.3390/toxics7020021
  • Sarath Josh MK, Pradeep S, Balan AK, et al. Accessing the molecular interactions of phthalates and their primary metabolites with the human pregnane X receptor using in silico profiling. J Appl Toxicol. 2016;36(12):1599–1604.
  • Sarath Josh MK, Pradeep S, Vijayalekshmi Amma KS, et al. Phthalates efficiently bind to human peroxisome proliferator activated receptor and retinoid X receptor α, β, γ subtypes: an in silico approach. J Appl Toxicol. 2014;34(7):754–765. DOI:10.1002/jat.2902
  • Sarath Josh MK, Pradeep S, Vijayalekshmy Amma KS, et al. Human ketosteroid receptors interact with hazardous phthalate plasticizers and their metabolites: an in silico study. J Appl Toxicol. 2016;36(6):836–843. DOI:10.1002/jat.3221
  • Johns LE, Ferguson KK, Cantonwine DE, et al. Urinary BPA and phthalate metabolite concentrations and plasma vitamin D Levels in pregnant women: a repeated measures analysis. Environ Health Perspect. 2017;125(8):087026.
  • Dutta S, Haggerty DK, Rappolee DA, et al. Phthalate exposure and long-term epigenomic consequences: a review. Front Genet. 2020;11:405.
  • Ferguson KK, Cantonwine DE, Rivera-González LO, et al. Urinary phthalate metabolite associations with biomarkers of inflammation and oxidative stress across pregnancy in Puerto Rico. Environ Sci Technol. 2014;48(12):7018–7025. DOI:10.1021/es502076j
  • Waits A, Chen HC, Kuo PL, et al. Urinary phthalate metabolites are associated with biomarkers of DNA damage and lipid peroxidation in pregnant women - Tainan Birth Cohort Study (TBCS). Environ Res. 2020;188:109863.
  • Grindler NM, Vanderlinden L, Karthikraj R, et al. Exposure to phthalate, an endocrine disrupting chemical, alters the first trimester placental methylome and transcriptome in women. Sci Rep. 2018;8(1):6086. DOI:10.1038/s41598-018-24505-w
  • Jiang HH, Du YY, Li YF. Ovarian toxicity and epigenetic mechanisms of phthalates and their metabolites. Curr Med Sci. 2021;41(2):236–249.
  • Hernández-Díaz S, Mitchell AA, Kelley KE, et al. Medications as a potential source of exposure to phthalates in the U.S. population. Environ Health Perspect. 2009;117(2):185–189.
  • Hauser R, Duty S, Godfrey-Bailey L, et al. Medications as a source of human exposure to phthalates. Environ Health Perspect. 2004;112(6):751–753.
  • Broe A, Pottegard A, Hallas J, et al. Phthalate exposure from drugs during pregnancy and possible risk of preterm birth and small for gestational age. Eur J Obstet Gynecol Reprod Biol. 2019;240:293–299.
  • Santos S, Sol CM, van Zwol-Janssens C, et al. Maternal phthalate urine concentrations, fetal growth and adverse birth outcomes. A population-based prospective cohort study. Environ Int. 2021;151:106443.
  • Ferguson KK, Rosen EM, Rosario Z, et al. Environmental phthalate exposure and preterm birth in the PROTECT birth cohort. Environ Int. 2019;132:105099.
  • Gao H, Wang YF, Huang K, et al. Prenatal phthalate exposure in relation to gestational age and preterm birth in a prospective cohort study. Environ Res. 2019;176:108530.
  • JMY H, Arbuckle TE, Janssen P, et al. Associations of prenatal urinary phthalate exposure with preterm birth: the Maternal-Infant Research on Environmental Chemicals (MIREC) Study. Can J Public Health. 2020;111(3):333–341. DOI:10.17269/s41997-020-00322-5
  • Boss J, Zhai J, Aung MT, et al. Associations between mixtures of urinary phthalate metabolites with gestational age at delivery: a time to event analysis using summative phthalate risk scores. Environ Health. 2018;17(1):56. DOI:10.1186/s12940-018-0400-3
  • Ferguson KK, McElrath TF, Meeker JD. Environmental phthalate exposure and preterm birth. JAMA Pediatr. 2014;168(1):61–67.
  • Ferguson KK, Chen YH, VanderWeele TJ, et al. Mediation of the relationship between maternal phthalate exposure and preterm birth by oxidative stress with repeated measurements across pregnancy. Environ Health Perspect. 2017;125(3):488–494.
  • Ferguson KK, McElrath TF, Chen YH, et al. Urinary phthalate metabolites and biomarkers of oxidative stress in pregnant women: a repeated measures analysis. Environ Health Perspect. 2015;123(3):210–216.
  • Shoaff JR, Romano ME, Yolton K, et al. Prenatal phthalate exposure and infant size at birth and gestational duration. Environ Res. 2016;150:52–58.
  • Chiu YH, Bellavia A, James-Todd T, et al. Evaluating effects of prenatal exposure to phthalate mixtures on birth weight: a comparison of three statistical approaches. Environ Int. 2018;113:231–239.
  • Song Q, Li R, Zhao Y, et al. Evaluating effects of prenatal exposure to phthalates on neonatal birth weight: structural equation model approaches. Chemosphere. 2018;205:674–681.
  • Zhao Y, Chen L, Li LX, et al. Gender-specific relationship between prenatal exposure to phthalates and intrauterine growth restriction. Pediatr Res. 2014;76(4):401–408. DOI:10.1038/pr.2014.103
  • Botton J, Philippat C, Calafat AM, et al. Phthalate pregnancy exposure and male offspring growth from the intra-uterine period to five years of age. Environ Res. 2016;151:601–609.
  • Ferguson KK, Meeker JD, Cantonwine DE, et al. Urinary phthalate metabolite and bisphenol a associations with ultrasound and delivery indices of fetal growth. Environ Int. 2016;94:531–537.
  • Shirangi A, Wright J, Blair EM, et al. Occupational chemical exposures in pregnancy and fetal growth: evidence from the born in bradford study. Scand J Work Environ Health. 2020;46(4):417–428.
  • Lenters V, Portengen L, Rignell-Hydbom A, et al. Prenatal phthalate, perfluoroalkyl acid, and organochlorine exposures and term birth weight in three birth cohorts: multi-pollutant models based on elastic net regression. Environ Health Perspect. 2016;124(3):365–372. DOI:10.1289/ehp.1408933
  • LaRocca J, Binder AM, McElrath TF, et al. First-trimester urine concentrations of phthalate metabolites and phenols and placenta miRNA expression in a cohort of U.S. Women. Environ Health Perspect. 2016;124(3):380–387.
  • Zhu Y, Wan Y, Zhang B, et al. Relationship between maternal phthalate exposure and offspring size at birth. Sci Total Environ. 2018;612:1072–1078.
  • Watkins DJ, Milewski S, Domino SE, et al. Maternal phthalate exposure during early pregnancy and at delivery in relation to gestational age and size at birth: a preliminary analysis. Reprod Toxicol. 2016;65:59–66.
  • Guo J, Wu M, Gao X, et al. Meconium exposure to phthalates, sex and thyroid hormones, birth size and pregnancy outcomes in 251 mother–infant pairs from Shanghai. Int J Environ Res Public Health. 2020;17(21):7711. DOI:10.3390/ijerph17217711
  • Noor N, Ferguson KK, Meeker JD, et al. Pregnancy phthalate metabolite concentrations and infant birth weight by gradations of maternal glucose tolerance. Int J Hyg Environ Health. 2019;222(3):395–401. DOI:10.1016/j.ijheh.2018.12.005
  • Shaffer RM, Ferguson KK, Sheppard L, et al. Maternal urinary phthalate metabolites in relation to gestational diabetes and glucose intolerance during pregnancy. Environ Int. 2019;123:588–596.
  • Fisher BG, Frederiksen H, Andersson AM, et al. Serum phthalate and triclosan levels have opposing associations with risk factors for gestational diabetes mellitus. Front Endocrinol. 2018;9:99.
  • James-Todd TM, Chiu YH, Messerlian C, et al. Trimester-specific phthalate concentrations and glucose levels among women from a fertility clinic. Environ Health. 2018;17(1):55. DOI:10.1186/s12940-018-0399-5
  • Zhang YW, Gao H, Huang K, et al. A cohort study on association between the first trimester phthalates exposure and fasting blood glucose level in the third trimester. Zhonghua Liu Xing Bing Xue Za Zhi. 2017;38(3):388–392.
  • James-Todd TM, Meeker JD, Huang T, et al. Pregnancy urinary phthalate metabolite concentrations and gestational diabetes risk factors. Environ Int. 2016;96:118–126.
  • Desvergne B, Feige JN, Casals-Casas C. PPAR-mediated activity of phthalates: a link to the obesity epidemic? Mol Cell Endocrinol. 2009;304(1–2):43–48.
  • Bellavia A, Hauser R, Seely EW, et al. Urinary phthalate metabolite concentrations and maternal weight during early pregnancy. Int J Hyg Environ Health. 2017;220(8):1347–1355. DOI:10.1016/j.ijheh.2017.09.005
  • Werner EF, Braun JM, Yolton K, et al. The association between maternal urinary phthalate concentrations and blood pressure in pregnancy: the HOME Study. Environ Health. 2015;14:75.
  • Cantonwine DE, Meeker JD, Ferguson KK, et al. Urinary concentrations of bisphenol a and phthalate metabolites measured during pregnancy and risk of preeclampsia. Environ Health Perspect. 2016;124(10):1651–1655.
  • Philips EM, Trasande L, Kahn LG, et al. Early pregnancy bisphenol and phthalate metabolite levels, maternal hemodynamics and gestational hypertensive disorders. Hum Reprod. 2019;34(2):365–373.
  • Ferguson KK, McElrath TF, Cantonwine DE, et al. Phthalate metabolites and bisphenol-A in association with circulating angiogenic biomarkers across pregnancy. Placenta. 2015;36(6):699–703.
  • Nikuei P, Rajaei M, Roozbeh N, et al. Diagnostic accuracy of sFlt1/PlGF ratio as a marker for preeclampsia. Bmc Pregnancy Childbirth. 2020;20(1):80. DOI:10.1186/s12884-020-2744-2
  • Su TC, Hwang JS, Torng PL, et al. Phthalate exposure increases subclinical atherosclerosis in young population. Environ Pollut. 2019;250:586–593.
  • Armant DR, Fritz R, Kilburn BA, et al. Reduced expression of the epidermal growth factor signaling system in preeclampsia. Placenta. 2015;36(3):270–278. DOI:10.1016/j.placenta.2014.12.006
  • Yi H, Gu H, Zhou T, et al. A pilot study on association between phthalate exposure and missed miscarriage. Eur Rev Med Pharmacol Sci. 2016;20(9):1894–1902.
  • Gao H, Zhang YW, Huang K, et al. Urinary concentrations of phthalate metabolites in early pregnancy associated with clinical pregnancy loss in Chinese women. Sci Rep. 2017;7(1):6800. DOI:10.1038/s41598-017-06450-2
  • Messerlian C, Wylie BJ, Mínguez-Alarcón L, et al. Urinary concentrations of phthalate metabolites and pregnancy loss among women conceiving with medically assisted reproduction. Epidemiology. 2016;27(6):879–888. DOI:10.1097/EDE.0000000000000525
  • Hannon PR, Flaws JA. The effects of phthalates on the ovary. Front Endocrinol. 2015;6:8.
  • Andersen LB, Jorgensen JS, Jensen TK, et al. Vitamin D insufficiency is associated with increased risk of first-trimester miscarriage in the Odense Child Cohort. Am J Clin Nutr. 2015;102(3):633–638. DOI:10.3945/ajcn.114.103655
  • Bornehag CG, Carlstedt F, Jönsson BA, et al. Prenatal phthalate exposures and anogenital distance in Swedish boys. Environ Health Perspect. 2015;123(1):101–107. DOI:10.1289/ehp.1408163
  • Sathyanarayana S, Grady R, Barrett ES, et al. First trimester phthalate exposure and male newborn genital anomalies. Environ Res. 2016;151:777–782.
  • Swan SH, Sathyanarayana S, Barrett ES, et al. First trimester phthalate exposure and anogenital distance in newborns. Hum Reprod. 2015;30(4):963–972. DOI:10.1093/humrep/deu363
  • Jensen TK, Frederiksen H, Kyhl HB, et al. Prenatal exposure to phthalates and anogenital distance in male infants from a low-exposed danish cohort (2010-2012). Environ Health Perspect. 2016;124(7):1107–1113. DOI:10.1289/ehp.1509870
  • Muerköster AP, Frederiksen H, Juul A, et al. Maternal phthalate exposure associated with decreased testosterone/LH ratio in male offspring during mini-puberty. Odense Child Cohort Environ Int. 2020;144:106025.
  • Di Renzo GC. The great obstetrical syndromes 1. J Matern Fetal Neonatal Med. 2009;22(8):633–635.
  • Biondi O. Low molecular weight polyethylene glycol induces chromosome aberrations in Chinese hamster cells cultured in vitro. Mutagenesis. 2002;17(3):261–264.
  • Yahya EB, Alqadhi AM. Recent trends in cancer therapy: a review on the current state of gene delivery. Life Sci. 2021;269:119087.
  • Jummaat F, Yahya EB, Khalil HPSA, et al. The role of biopolymer-based materials in obstetrics and gynecology applications: a review. Polymers. 2021;13(4):633.
  • Racicot K, Kwon JY, Aldo P, et al. Understanding the complexity of the immune system during pregnancy. Am J Reprod Immunol. 2014;72(2):107–116.
  • Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860–867.
  • BH LH, Lamont RF, Lamont RF. Safety of antimicrobial treatment during pregnancy: a current review of resistance, immunomodulation and teratogenicity. Expert Opin Drug Saf. 2014;12:1569–1581.
  • Lamont RF, Moller Luef B, Stener Jorgensen J. Childhood inflammatory and metabolic disease following exposure to antibiotics in pregnancy, antenatally, intrapartum and neonatally. F1000Res. 2020;9:144.
  • Milliken S, Allen RM, Lamont RF. The role of antimicrobial treatment during pregnancy on the neonatal gut microbiome and the development of atopy, asthma, allergy and obesity in childhood. Expert Opin Drug Saf. 2019;18(3):173–185.
  • Škrlová K, Malachová K, Muñoz-Bonilla A, et al. Biocompatible polymer materials with antimicrobial properties for preparation of stents. Nanomaterials (Basel). 2019;9(11):1548.
  • Joseph B, George A, Gopi S, et al. Polymer sutures for simultaneous wound healing and drug delivery - a review. Int J Pharm. 2017;524(1–2):454–466.
  • Kamoun EA, Kenawy ES, Chen X. A review on polymeric hydrogel membranes for wound dressing applications: pVA-based hydrogel dressings. J Adv Res. 2017;8(3):217–233.
  • Christesen HT, Falkenberg T, Lamont RF, et al. The impact of vitamin D on pregnancy: a systematic review. Acta Obstet Gynecol Scand. 2012;91(12):1357–1367.
  • Bodnar LM, Krohn MA, Simhan HN. Maternal vitamin D deficiency is associated with bacterial vaginosis in the first trimester of pregnancy. JNutr. 2009;139(6):1157–1161.
  • McGuire DL, Chang SC, Mancini J, et al. Vitamin D insufficiency is prevalent among pregnant African American adolescents. JPediatrAdolescgynecol. 2009;23(1): 45–52.
  • Christesen HT, Elvander C, Lamont RF, et al. The impact of vitamin D in pregnancy on extraskeletal health in children: a systematic review. Acta Obstet Gynecol Scand. 2012;91(12):1368–1380.
  • Lamont RF. Spontaneous preterm labour that leads to preterm birth: an update and personal reflection. Placenta. 2019;79:21–29.
  • European Medicines Agency. Guideline on the use of phthalates as excipients in human medicinalproducts. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific-guideline/2014/11/WC500177736.pdf
  • US food and drug administration. Guidance for industry on limiting the use of certain phthalates as excipients in center for drug evaluation and research- regulated products; availability. Dec 2012. https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryIn-formation/Guidances/UCM294086.pdf
  • Yen TH, Lin-Tan DT, Lin JL. Food safety involving ingestion of foods and beverages prepared with phthalate-plasticizer-containing clouding agents. J Formos Med Assoc. 2011;110(11):671–684.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.